Sesen Bio Inc.

NASDAQ:SESN   3:59:52 PM EDT
0.96
+0.07 (+8.27%)
4:24:33 PM EDT: $0.97 +0.01 (+1.14%)
Earnings Announcements

Sesen Bio Reports Fourth Quarter And Full-Year 2020 Results

Published: 03/15/2021 11:49 GMT
Sesen Bio Inc. (SESN) - Sesen Bio Reports Fourth Quarter and Full-year 2020 Financial Results and Significant Regulatory and Commercial Readiness Progress for the Company’s Lead Product Candidate Vicineum™.
Q4 Loss per Share $0.11.
Q4 Earnings per Share Estimate $-0.10 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.53 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $3.14 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.